Literature DB >> 22517484

Clinical significance of SOD2 and GSTP1 gene polymorphisms in Chinese patients with gastric cancer.

Zhi Xu1, Haixia Zhu, John M Luk, Dongmei Wu, Dongying Gu, Weida Gong, Yongfei Tan, Jianwei Zhou, Jinhai Tang, Zhengdong Zhang, Meilin Wang, Jinfei Chen.   

Abstract

BACKGROUND: Excessive reactive oxygen species (ROS) accumulation is a common phenomenon in carcinogenesis. However, the rationale behind ROS involvement in gastric cancer is unclear. In this study, the authors investigated the clinical significance of the single nucleotide polymorphisms (SNPs) of 2 ROS metabolic process-related genes: superoxide dismutase 2 (SOD2) and glutathione S-transferase π (GSTP1).
METHODS: In total of 929 patients with gastric cancer who had definitive clinicopathologic and follow-up data were collected. SOD2 reference SNP 4880 (rs4880) and GSTP1 rs1695 genotyping were examined in DNA samples extracted from paraffin-embedded tumor tissue. Association of the 2 SNPs with each clinicopathologic feature was analyzed using the Pearson chi-square test and the independent Student t test. Gastric cancer-specific overall survival was analyzed using Kaplan-Meier curves and log-rank tests. Multivariate Cox regression analyses of these SNPs also were performed.
RESULTS: The SOD2 rs4880 CT + CC genotypes were significantly associated with a high level of lymph node metastasis (P = .023), whereas the GSTP1 rs1695 GA + GG genotypes were significantly associated with larger tumor size (>5 cm long; P = .048). Kaplan-Meier and Cox regression data indicated that the SOD2 rs4880 CT + CC genotypes alone (hazard ratio, 1.299; 95% confidence interval, 1.053-1.603; P = .015) and the GSTP1 rs1695 GA + GG combined genotypes (hazard ratio, 1.496; 95% CI, 1.078-2.074; P = .016) were independent predictors for overall survival.
CONCLUSIONS: The current data, based on a large cohort (n = 929) of Chinese patients with gastric cancer, suggested that the presence of SOD2 rs4880 and GSTP1 rs1695 genotypes may contribute to cancer progression as well as tumor aggressiveness. The components of ROS metabolism pathways may be potential therapeutic targets for this aggressive malignancy.
Copyright © 2012 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22517484     DOI: 10.1002/cncr.27599

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  24 in total

1.  Glutathione S-transferase, catalase, and mitochondrial superoxide dismutase gene polymorphisms modulate redox potential in systemic lupus erythematosus patients from Manaus, Amazonas, Brazil.

Authors:  Marco Aurélio Almeida de Oliveira; Neila Hiraishi Mallmann; Giselle Katiane Bonfim Bacellar de Souza; Thiago de Jesus Bacha; Emerson Silva Lima; Domingos Sávio Nunes de Lima; Luiz Fernando de Souza Passos; Marilda de Souza Gonçalves; José Pereira de Moura Neto
Journal:  Clin Rheumatol       Date:  2021-03-20       Impact factor: 2.980

Review 2.  Genetics and gastric cancer susceptibility.

Authors:  Yan Lu; Fang Lu; Sha Zeng; Suqing Sun; Li Lu; Lifeng Liu
Journal:  Int J Clin Exp Med       Date:  2015-06-15

3.  Influences of ERCC1, ERCC2, XRCC1, GSTP1, GSTT1, and MTHFR polymorphisms on clinical outcomes in gastric cancer patients treated with EOF chemotherapy.

Authors:  Rujiao Liu; Xiaoying Zhao; Xin Liu; Zhiyu Chen; Lixin Qiu; Ruixuan Geng; Weijian Guo; Guang He; Jiliang Yin; Jin Li; Xiaodong Zhu
Journal:  Tumour Biol       Date:  2015-08-28

4.  SOD2 rs4880 CT/CC genotype predicts poor survival for Chinese gastric cancer patients received platinum and fluorouracil based adjuvant chemotherapy.

Authors:  Zhi Xu; Yi Chen; Dongying Gu; Nikki P Lee; Stella Sun; Weida Gong; Yongfei Tan; John M Luk; Jinfei Chen
Journal:  Am J Transl Res       Date:  2015-02-15       Impact factor: 4.060

5.  Association study of SNPs of genes IFNGR1 (rs137854905), GSTT1 (rs71748309), and GSTP1 (rs1695) in gastric cancer development in samples of patient in the northern and northeastern Brazil.

Authors:  Rubistenia Miranda Soares de Araújo; Cynthia Farias Vieira de Melo; Fidelis Manes Neto; Juarez Nóbrega da Silva; Leonardo Ferreira Soares; Marilia de Arruda Cardoso Smith; Edilson Carvalho Sousa; Rommel Mario Rodríguez Burbano; Arnaldo Correia de Medeiros; Eleonidas Moura Lima
Journal:  Tumour Biol       Date:  2014-01-23

6.  Polymorphisms of glutathione S-transferase genes and survival of resected hepatocellular carcinoma patients.

Authors:  Kai Qu; Su-Shun Liu; Zhi-Xin Wang; Zi-Chao Huang; Si-Nan Liu; Hu-Lin Chang; Xin-Sen Xu; Ting Lin; Ya-Feng Dong; Chang Liu
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

7.  Glutathione S-transferase A1 mediates nicotine-induced lung cancer cell metastasis by promoting epithelial-mesenchymal transition.

Authors:  Wei Wang; Feiyu Liu; Chaoyang Wang; Chengde Wang; Yijun Tang; Zhongmin Jiang
Journal:  Exp Ther Med       Date:  2017-06-23       Impact factor: 2.447

8.  Prognostic value of diffuse versus intestinal histotype in patients with gastric cancer: a systematic review and meta-analysis.

Authors:  Fausto Petrelli; Rosa Berenato; Luca Turati; Alessia Mennitto; Francesca Steccanella; Marta Caporale; Pierpaolo Dallera; Filippo de Braud; Ezio Pezzica; Maria Di Bartolomeo; Giovanni Sgroi; Vincenzo Mazzaferro; Filippo Pietrantonio; Sandro Barni
Journal:  J Gastrointest Oncol       Date:  2017-02

9.  Glutathione S-transferase P1 gene rs4147581 polymorphism predicts overall survival of patients with hepatocellular carcinoma: evidence from an enlarged study.

Authors:  Zhixin Wang; Kai Qu; Wenquan Niu; Ting Lin; Xinsen Xu; Zichao Huang; Sushun Liu; Sinan Liu; Hulin Chang; Yamin Liu; Xiaoqun Dong; Chang Liu; Yuelang Zhang
Journal:  Tumour Biol       Date:  2015-08-11

Review 10.  CYP1A1 and GSTP1 gene variations in breast cancer: a systematic review and case-control study.

Authors:  Sumaira Akhtar; Ishrat Mahjabeen; Zertashia Akram; Mahmood Akhtar Kayani
Journal:  Fam Cancer       Date:  2016-04       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.